<DOC>
	<DOCNO>NCT00013572</DOCNO>
	<brief_summary>The purpose study determine best way administer candidate HIV vaccine , ALVAC HIV-1 ( vCP205 ) .</brief_summary>
	<brief_title>HIV Candidate Vaccine , ALVAC-HIV-1 , Administration HIV-Negative Adults</brief_title>
	<detailed_description>Healthy adult volunteer assign randomly either vaccine placebo group . Injections receive either intramuscularly , intradermally , delivery skin volunteer 's white blood cell dendritic cell reinfusion . Volunteers vaccinate 0 , 1 , 3 , 6 month time point . Volunteers closely monitor 1 hour vaccination keep diary symptom 1 week post-immunization . Volunteers undergo leukopheresis start study last vaccination Walter Reed Army Medical Center . Volunteers receive compensation benefit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria Volunteers may eligible study : Are legal US resident . Are healthy adult 18 55 year age . Exclusion Criteria Volunteers eligible study : Are HIVpositive . Are high risk HIV infection . Are pregnant breastfeeding . Are allergic egg neomycin . Use certain prescription medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2003</verification_date>
	<keyword>Injections , Intramuscular</keyword>
	<keyword>Injections , Intradermal</keyword>
	<keyword>Injections , Subcutaneous</keyword>
	<keyword>HIV-1</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>Dendritic Cells</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Genes , env</keyword>
	<keyword>Genes , pol</keyword>
	<keyword>Genes , gag</keyword>
	<keyword>Transfection</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>